Search results for "Hazard"

showing 10 items of 1517 documents

The association of uric acid with mortality modifies at old age: data from the uric acid right for heart health (URRAH) study

2021

Objectives: In older individuals, the role of serum uric acid (SUA) as risk factor for mortality is debated. This study investigated the association of SUA with all-cause and cardiovascular (CV) mortality in older adults participating in the large multicentre observational uric acid right for heart health (URRAH) study. Methods: Eight thousand URRAH participants aged 65+ were included in the analysis. The predictive role of SUA was assessed using Cox regression models stratified according to the cut-off age of 75. SUA was tested as continuous and categorical variable (age-specific quartiles). The prognostic threshold of SUA for mortality was analysed using receiver operating characteristic …

Settore MED/09 - Medicina InternahypertensionPhysiologyAged; Humans; Prognosis; Proportional Hazards Models; Risk Factors; Uric Aciduric acid; hypertension; elderly; cardiovascular prevention; stroke; myocardial infarctionAcid Urc mortality old agePrognosisCardiovascular riskelderlystrokeolder adultCardiovascular preventionmyocardial infarctionRisk FactorsOlder adultsCardiovascular prevention; Cardiovascular risk; Mortality; Older adults; Uric acidInternal MedicineHumansMortalityCardiology and Cardiovascular MedicineUric acidAgedProportional Hazards Models
researchProduct

Modello di regressione esteso per l'analisi semiparametrica dei dati di sopravvivenza

Settore SECS-S/01 - Statisticasopravvivenza hazard accelerated failure time model accelerated hazard model extended hazard model
researchProduct

Active tectonics, sedimentation history and geomorphological features in the northern Sicily continental margin: implications for the marine geohazar…

2020

Starting from the assumption that seismic events in the active margins are accompanied by evidence of a depositional, geomorphologic and structural type, which constitutes the geological record of their activity, we analysed different features of the Northern Sicily continental margin (NSCM) to reconstruct the deformational field and related stress field in the Southern Tyrrhenian sea. As an outcome of this project we were going to obtain seismotectonic setting and mapping to provide a powerful tool in managing and assessing the marine geological hazards. The study area extends from the San Vito Peninsula to the Termini Gulf along the NSCM, including the Ustica island, and is located in a t…

Sicilian continental marginBackthrustTsunami Geo-hazardSettore GEO/02 - Geologia Stratigrafica E SedimentologicaSlope instabilityActive TectonicSeismotectonic map
researchProduct

Identification and Evaluation of Hazardous Pyrolysates in Bio-Based Rigid Polyurethane-Polyisocyanurate Foam Smoke

2021

In this study, rigid polyurethane (PU) and polyisocyanurate (PIR) foam samples made from renewable material (tall oil fatty acid) based polyols were analyzed by pyrolysis gas chromatography mass spectrometry (Py-GC/MS) to obtain information about the full relative smoke content, with a focus on substance identification by their functional groups and hazardousness. The relative content of gaseous products produced during the thermal degradation was evaluated between the two samples, differenced by their assigned isocyanate (NCO) index value—150 and 300. The main thermal degradation components of the rigid PU-PIR foam were found to originate from the decomposition of isocyanate, primarily for…

Smokebusiness.product_categoryPolymers and Plasticsanalytical pyrolysisenvironmental hazardsTall oilPolyisocyanurateOrganic chemistryGeneral ChemistryIsocyanateDecompositionrigid PU-PIR foam; analytical pyrolysis; physical hazards; health hazards; environmental hazardsArticlechemistry.chemical_compoundPyrolysis–gas chromatography–mass spectrometryQD241-441Anilinechemistryhealth hazardsrigid PU-PIR foamphysical hazardsOrganic chemistrybusinessPolyurethanePolymers
researchProduct

Sorafenib in advanced hepatocellular carcinoma

2008

none 25 BACKGROUND: No effective systemic therapy exists for patients with advanced hepatocellular carcinoma. A preliminary study suggested that sorafenib, an oral multikinase inhibitor of the vascular endothelial growth factor receptor, the platelet-derived growth factor receptor, and Raf may be effective in hepatocellular carcinoma. METHODS: In this multicenter, phase 3, double-blind, placebo-controlled trial, we randomly assigned 602 patients with advanced hepatocellular carcinoma who had not received previous systemic treatment to receive either sorafenib (at a dose of 400 mg twice daily) or placebo. Primary outcomes were overall survival and the time to symptomatic progression. Seconda…

SorafenibMaleNiacinamidemedicine.medical_specialtyCarcinoma HepatocellularPyridinesPlaceboGastroenterologyDouble-Blind MethodInternal medicinemedicineCarcinomaHumansHEPATOCELLULAR CARCINOMAProtein Kinase InhibitorsAgedNeoplasm StagingProportional Hazards Modelsbusiness.industryPhenylurea CompoundsHazard ratioBenzenesulfonatesLiver NeoplasmsGeneral MedicineTREATMENTMiddle AgedSorafenibmedicine.diseaseInterim analysisSurvival AnalysisRecurrent Hepatocellular Carcinomadigestive system diseasesSurgeryHEPATOCELLULAR CARCINOMA; SORAFENIB; TREATMENTChemotherapy AdjuvantHepatocellular carcinomaDisease ProgressionFemaleraf KinasesbusinessLiver cancermedicine.drug
researchProduct

Survival analysis of proposed BCLC-B subgroups in hepatocellular carcinoma patients

2013

Background & Aims The BCLC-staging system is used to facilitate treatment decisions in patients with hepatocellular carcinoma (HCC). Owing to the observed clinical heterogeneity of the intermediate stage BCLC-B, a subclassification was proposed taking Child–Pugh score and extended criteria for transplantation into account. Analysis of the prognostic significance of a proposed subclassification of the BCLC-B score in a European cohort of HCC patients. Methods Eight hundred and eighty four consecutive HCC patients were retrospectively analysed. Patients with stage BCLC-B were grouped according to the proposed subclassification. Baseline patient and tumour characteristics, therapy and overall …

SorafenibOncologymedicine.medical_specialtyCarcinoma HepatocellularStatistics NonparametricInternal medicineHumansMedicineStage (cooking)Survival analysisNeoplasm StagingRetrospective StudiesHepatologybusiness.industryProportional hazards modelLiver NeoplasmsPrognosismedicine.diseaseSurvival AnalysisSurgeryEuropeTransplantationHepatocellular carcinomaCohortRegression AnalysisLiver functionbusinessmedicine.drugLiver International
researchProduct

Improved prediction of survival by a risk factor-integrated inflammatory score in Sorafenib treated hepatocellular carcinoma

2017

Background and aims Inflammation affects progression of hepatocellular carcinoma (HCC). We therefore postulate that systemic inflammatory markers could help to predict prognosis in HCC patients receiving sorafenib therapy. Methods Overall survival (OS) of HCC patients receiving palliative sorafenib treatment was correlated with the neutrophil to lymphocyte ratio (NLR), platelet to lymphocyte ratio (PLR), C-reactive protein to albumin ratio (CAR), Glasgow prognostic score (GPS) and the modified GPS (mGPS) along with clinicopathological parameters. Predictors of OS were assessed by multivariable Cox regression and receiver operating characteristics and area under the curve (ROC-AUC) analyses.…

SorafenibOncologymedicine.medical_specialtyHepatologyReceiver operating characteristicProportional hazards modelbusiness.industryArea under the curvemedicine.diseasedigestive system diseases03 medical and health sciences0302 clinical medicine030220 oncology & carcinogenesisInternal medicineHepatocellular carcinomaCohortmedicine030211 gastroenterology & hepatologyRisk factorNeutrophil to lymphocyte ratiobusinessneoplasmsmedicine.drugJournal of Hepatology
researchProduct

Ramucirumab in elderly patients with hepatocellular carcinoma and elevated alpha-fetoprotein after sorafenib in REACH and REACH-2.

2020

Background & Aims: Limited data on treatment of elderly patients with hepatocellular carcinoma (HCC) increase the unmet need. REACH and REACH-2 were global phase III studies of ramucirumab in patients with HCC after prior sorafenib, where patients with alpha-fetoprotein (AFP) ≥400 ng/mL showed an overall ssurvival (OS) benefit for ramucirumab. These post-hoc analyses examined efficacy and safety of ramucirumab in patients with HCC and baseline AFP ≥ 400 ng/mL by three prespecified age subgroups (<65, ≥65 to <75 and ≥75 years). Methods: Individual patient data were pooled from REACH (baseline AFP ≥400 ng/mL) and REACH-2. Kaplan-Meier and Cox proportional hazards regression methods …

Sorafenibmedicine.medical_specialtyCarcinoma HepatocellularHepatocellular carcinoma[SDV.CAN]Life Sciences [q-bio]/CancerSorafenib intolerancePlaceboAntibodies Monoclonal HumanizedGastroenterologyRamucirumabRamucirumabCàncer de fetge03 medical and health sciences0302 clinical medicineElderlyInternal medicineCox proportional hazards regressionMedicineHumansAgedHepatologyElevated alpha-fetoproteinbusiness.industryPersones grans dependentsHazard ratioLiver Neoplasms[SDV.MHEP.HEG]Life Sciences [q-bio]/Human health and pathology/Hépatology and GastroenterologyHepatitis CSorafenibmedicine.diseaseFrail elderly3. Good healthVEGFR2Treatment Outcome030220 oncology & carcinogenesisHepatocellular carcinoma[SDV.SP.PHARMA]Life Sciences [q-bio]/Pharmaceutical sciences/Pharmacology030211 gastroenterology & hepatologyMonoclonal antibodiesAlpha-fetoprotein (AFP)alpha-FetoproteinsbusinessAnticossos monoclonalsLiver cancermedicine.drugLiver international : official journal of the International Association for the Study of the LiverREFERENCES
researchProduct

Sorafenib in advanced hepatocellular carcinoma – We have won a battle not the war

2008

Sorafenib in advanced hepatocellular carcinoma. Llovet JM, Ricci S, Mazzaferro V, Hilgard P, Gane E, Blanc JF, de Oliveira AC, Santoro A, Raoul JL, Forner A, Schwartz M, Porta C, Zeuzem S, Bolondi L, Greten TF, Galle PR, Seitz JF, Borbath I, Haussinger D, Giannaris T, Shan M, Moscovici M, Voliotis D, Bruix J; SHARP Investigators Study Group. Background No effective systemic therapy exists for patients with advanced hepatocellular carcinoma. A preliminary study suggested that sorafenib, an oral multi-kinase inhibitor of the vascular endothelial growth factor receptor, the platelet-derived growth factor receptor, and Raf may be effective in hepatocellular carcinoma. Methods In this multicente…

Sorafenibmedicine.medical_specialtyHepatologybusiness.industryHazard ratiomedicine.diseaseInterim analysisPlaceboGastroenterologyPlacebo groupSystemic therapydigestive system diseasesConfidence intervalSurgeryInternal medicineHepatocellular carcinomamedicinebusinessmedicine.drugJournal of Hepatology
researchProduct

Steam and gas emission rate from La Soufriere volcano, Guadeloupe (Lesser Antilles): implications for the magmatic and hydrothermal fluid supply duri…

2014

Since its last magmatic eruption in 1530 AD, La Soufrière andesitic volcano in Guadeloupe has displayed intense hydrothermal activity and six phreatic eruptive crises. Here we report on the first direct quantification of gas plume emissions from its summit vents,which gradually intensified during the past 20 years. Gas fluxes were determined in March 2006 and March 2012 by measuring the horizontal and vertical distributions of volcanic gas concentrations in the air-diluted plume and scaling to the speed of plume transport. Fluxes in 2006 combine realtime measurements of volcanic H2S concentrations and plume parameters with the composition of the hot (108.5 °C) fumarolic fluid at exit. Fluxe…

Soufrière of Guadeloupe Volcanic gas fluxes Heat output Magma degassing budget Volcanic hazardSettore GEO/08 - Geochimica E Vulcanologia
researchProduct